Presentation Choice of eGFR Equation Impacts Drug-Dosing Recommendations and Risk Stratification in CKD Patients Undergoing PCI Presenter: J. Parsh June 26, 2015
Presentation Clinical Outcomes of Treatment by PCI vs CABG in Patients With CKD Undergoing Index Revascularization Presenter: W. Chan January 21, 2015
Presentation The Effect of AKI After Revascularization on the Development of CKD and Mortality in Patients with Chronic Limb Ischemia Presenter: P. Arora January 13, 2015
Presentation Advanced CKD in Patients Undergoing TAVI: Insights on Clinical Outcomes, Prognostic Markers Presenter: 120694|Ricardo Allende May 07, 2014
Presentation Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD Presenter: Fabrizio Tomai January 07, 2014
Presentation TCT 2013 Current Status of Lipid Lowering Therapy in CAD, PAD, and CKD Presenter: Rita Redberg October 27, 2013
Presentation TCT 2012 P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.) Presenter: Dirk Sibbing October 22, 2012
Presentation Impact of Clopidogrel Loading Dose in Patients with CKD Undergoing Primary PCI for STEMI Presenter: 56196|JY Kim September 14, 2012
Presentation TCT 2012 Relationship between SYNTAX Score and Contrast Induced Acute Kidney Injury in Patients with CKD undergoing Coronary Angiography or PCI Presenter: Ayesha C. Qureshi, Roshan Weerackody, Muhiddin Ozkor, Magdi Yaqoob, Akhil Kapur January 03, 2012
Presentation TCT 2012 Objectives: The purpose of this study was to determine the functional impact of cilostazol in patients with chronic kidney disease (CKD) undergoing hemodialysis. Presenter: Weon Kim, Won-Yu Kang, Jong-Shin Woo January 03, 2012